Delivery Order SPE2DR25D3016-SPE2DR26FG3JS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency has awarded a delivery order valued at $9,204.95 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 3, 2025. The award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This...
- The Defense Logistics Agency awarded a $15,753.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on December 2, 2025, with an ultimate completion date of December 3, 2025. This competitive award, which was not set-aside for any specific business category, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,086.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,531.04 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $3,616.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, issued on December 30, 2025, with completion targeted for December 31, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order through its Corporate Office division. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,287.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of October 23, 2025. This non-set-aside contract represents a single delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,963.24 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award is a child contract under Cencora, Inc. (which...
- The Defense Logistics Agency awarded a $25,216.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 8, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, with an ultimate completion date of January 9, 2026, will be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG3JSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,854.10 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors, with an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs. This delivery order was issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds the primary IDC with the Defense Logistics Agency through December 31, 2031, which enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Zepbound, a prescription diabetes medication, represents one of the diverse pharmaceutical products supplied through this contract vehicle to support military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 1/13/26 |